| Data Request ID | Researcher’s Name | Researcher’s Affiliation | Data Request Title | Data Contributors |
|---|---|---|---|---|
| 8010, 8011, 8013, 8014 | Moska Hellamand | Access To Medicine Foundation, Netherlands | Assessment of datasets shared on the AMR Register | GSK, Johnson & Johnson, Pfizer, Shionogi |
| 8055 | Jose Lopez Revilla | Instituto Nacional de salud del Niño San Borja, Peru | The impact of resistance on sepsis mortality in pediatrics | Pfizer |
| 8173 | Catrin Moore | St. George’s, University of London, UK | ADILA (AMR data for local action) | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 8235 | Megan Coffee | Mailman School of Public Health, USA | Nigeria AMR | Pfizer, Shionogi, Venatorx |
| 8430 | Victoria Savage | Infex Therapeutics, UK | Establishing the prevalence of metallo-B-lactamases and carbapenem-resistance in Gram negative pathogens | Merck, Pfizer |
| 8432 | Ghanshyam Lad | Independent researcher, India | The trend of antibiotic resistance of tetracycline in adults in recent years | Pfizer |
| 8447, 8594 8595, 8596 | Benn Sartorius | University of Oxford, UK | The Global Research on Antimicrobial Resistance (GRAM) Project | Paratek, Pfizer, Shionogi, Venatorx |
| 8544 | Gwen Knight | London School of Hygiene and Tropical Medicine, UK | Medical Research Council - Career Development Award (MRC CDA) fellowship project | GSK, Johnson & Johnson, Paratek, Shionogi, Venatorx |
| 8554 | Ying Huang | The Chinese University of Hong Kong, China | To explore pathogens and antibiotic susceptibility in hospital | Pfizer |
| 8612/8613 | Camille Andre | Harvard Medical School, USA | Epidemiology and antimicrobial resistance of bacteria causing eye infections | Paratek, Pfizer |
| 8745 | Ingrid Jacobson | University of Minnesota Twin Cities - Center for Infectious Disease Research and Prevention (CIDRAP), USA | Master's Thesis Project on Antifungal Resistance | Pfizer |
| 8811 | Naomi Waterlow | London School of Hygiene and Tropical Medicine, UK | AMR and age | GSK, Johnson & Johnson, Paratek, Pfizer, Venatorx |
| 8906 | Megan Coffee | NYU Langone | Diagnosis of Tuberculosis through computer-assisted detection | Johnson & Johnson |
| 8907 | Megan Coffee | NYU Langone | AMR Global Analysis of trends in genotypes of resistance | Paratek |
| 8911 | Dickson Aruhomukama | Makerere University College of Health Sciences | Data Challenge_Investigating the Evolution and Predicting the Future Outlook of Antimicrobial Resistance in sub-Saharan Africa Using Genotypic Data for Klebsiella pneumoniae: A 5-Year Analysis | Pfizer |
| 8920 | Omololu Fagunwa | Queens University Belfast | Insights into AMR trends and resistant pathogens in Middle-East and Africa | Johnson & Johnson, Merck, Paratek, Pfizer, Venatorx |
| 8923 | Robert Beardmore | University of Exeter/Universidad Carlos III/Westmead Hospital / University of Sydney | Data Challenge - Are antibiotic breakpoints globally consistent, does it matter if not? | Pfizer |
| 8928 | Mabel Aworh | North Carolina State University | Data Challenge - Phenotypic and Genomic Evolution of Antimicrobial Resistance among WHO Priority pathogens in LMICS | GSK, Paratek, Pfizer, Venatorx |
| 8930 | Kauke Bakari Zimbwe | The Benjamin Mkapa Hospital | Data challenge - Antimicrobial resistance trend and clinical implications of WHO priority pathogens from urine, blood and wounds | Johnson & Johnson, Pfizer, Venatorx |
| 8932 | Megan Coffee | NYU Grossman School of Medicine | Data Challenge - Building the macro from the micro: towards predictive analytic models for country-wide prediction of antimicrobial resistance | Pfizer, Shionogi |
| 8936 | Rik Oldenkamp | Universiteit Amsterdam | Data Challenge - Spatiotemporal modelling of antimicrobial resistance in key gram-negative pathogens: Deciphering global patterns using indirect predictors | Pfizer, Venatorx |
| 8938 | Ifeanyi Elibe | University of Ibadan | Data Challenge - Phenotypic assays analysis and Meta-analysis of whole genome sequencing studies of Klebsiella pneumonia, Escherichia coli, and Enterobacter spp. reveals multiple AMR patterns and diverse MDR lineages spread across Africa | Pfizer, Venatorx |
| 8939 | Saviour Atuheire | Makerere University College of Health Sciences | Data Challenge - Aeromonas resistance | Pfizer |
| 8940 | Nalugya Flavia | Makerere University | Data Challenge - correlation between antibiotic consumption patterns and the emergence of antimicrobial resistance (AMR) in specific bacterial strains in different regions | GSK, Pfizer |
| 8941 | Amusa Wamawobe | Makerere University | Data Challenge - Designing a PCR Test for Detecting Antimicrobial Resistance Markers in Gram-Negative Bacteria in Africa Using Genotypic AMR Data from Multiple Countries | Pfizer |
| 8943 | Muditha Hapudeniya | Ministry of Health, Sri Lanka | Data Challenge - Application of statistical and machine learning methods to predict antimicrobial susceptibility to blood borne microorganisms to support administrative and policy level decision making | Pfizer |
| 8945 | Obed Amponsah | Kwame Nkrumah University of Science and Technology | Antibiotic Resistance Patterns in Africa Using the Pfizer ATLAS Surveillance System _ Open Data Challenge | Pfizer |
| 8951 | Mugerwa Moses | Tufaayo Foundation | Data Challenge: Exploring the Link Between Gram-Negative Pathogen Resistance and Omadacycline Effectiveness | Paratek, Venatorx |
| 8952 | Stephen Opiyo | Patira Data Science | Data Challenge - Unleashing the Power of AI: Harnessing Vivli Data from Kenya to Unlock the Untapped Potential of AMR Data from Uganda | Pfizer |
| 8961 | Ndugwa Henry | International center of insect physiology and ecology | Data Challenge: Predicting Antimicrobial resistance in different geographical locations, micobes, antimicrobial classes and infection types using spatial temporal analysis | Pfizer |
| 8964 | Bonface Onyango | International center of insect physiology and ecology | Data Challenge - Global Antimicrobial Resistance Trends and Patterns Identification using Machine Learning | Pfizer |
| 8990 | Babafela Awosile | Texas Tech University School of Veterinary Medicine | Data Challenge - Predictive modeling of phenotypic antimicrobial susceptibility of selected critical and high-priority antimicrobials from antimicrobial resistance genes | Pfizer |
| 8995 | Fredrick Mutisya | Narok County Government | Data Challenge: Application of artificial intelligence methods in AMR | Pfizer |
| 9005, 9020 | Kenneth Irungu | Ministry if Health, Kenya | Data challenge: respiratory tract infections; is it true resistance or does penicillin work | GSK, Venatorx |
| 9006 | Ivan Lumu | Infectious Diseases Institute, Makerere University | Data Challenge - Developing tools to improve empirical treatment in low and middle income countries | GSK, Paratek, Pfizer, Shionogi, Venatorx, |
| 9013 | Adebiyi Sefiyat Odunola | Stellenboch University | Data Challenge: Unlocking AMR Landscape: Decoding National, Regional and Global Trends and Predicting Hotspots for a Resilient Future using the ATLAS, GEAR and ResistanceMap Databases, 2004-2021 | Pfizer, Venatorx |
| 9017 | Samra Qadri | Shaheed Zulfikar Ali Bhutto Institute of Science and Technology | Data Challenge - Gram Negative Pathogen and Antimicrobial resistance | Venatorx |
| 9022 | Josephat Hema | Swansea University | Data Challenge - Development and impact of carbapenem-resistant pseudomonas aeruginosa (CRPA) in selected low- and middle-income countries. | Pfizer |
| 9025 | Elizabeth Akande | University of Ibadan | AMR challenge - LAST RESORT THREATENED, WHAT NEXT? | Venatorx |
| 9029 | Tunde Egunjobi | Igbinedion University | Data Challenge - Ten-year Trends In Antimicrobial Resistance Amongst Pathogens Isolated From Clinical Samples. | Paratek, Pfizer, Venatorx |
| 9035 | Kessendri Reddy | Stellenbosch University and National Health Laboratory Service | Data Challenge: Long term trends in antimicrobial susceptibility to therapeutic options for carbapenem-resistant A. baumannii, K. pneumoniae and P. aeruginosa in Africa | Pfizer, Shionogi, Venatorx |
| 9038 | Mapoloko Theresia Moholoholo | Ministry of Health Lesotho | Data Challenge: Title : Global scenario of beta-lactams resistance in extraintestinal E.coli among pediatric patients: 2018-2021 | Venatorx |
| 9039 | Areena Hoda Siddiqui | Integral Institute of Medical Sciences and Reasearch, Integral University | Data Challenge-Colistin Sparing Strategies To Overcome Resistance: Can We Save Future ! | Pfizer, Venatorx |
| 9040 | Aishwarya Das | Central Research Laboratory, KIMS | Genomic surveillance of Antimicrobial resistance Data challenge | Pfizer |
| 9043 | Walter Kiirya | Mbarara University of science and technology | Community health workers knowledge about AMR data challenge | Pfizer |
| 9044 | Arryn Craney | Petrified Bugs LLC | Data Challenge - Trending Antibiotic Resistance Profiles | Paratek, Pfizer, Shionogi, Venatorx |
| 9045 | Suchitra Thapa | Tribhuvan University | Data Challenge: Changes in Fluoroquinolone susceptibility for Enterobacteriaceae among adult population in Asia: A trend analysis over a decade | Pfizer |
| 9047 | Imran Sajid | University of the Punjab, Lahore | Data Challenge-Unveiling Novel Resistance Mechanisms: Genomic Insights into Carbapenem-Resistant Gram-Negative Bacteria | Shionogi |
| 9048 | Vuciri Jude Rugga | Ssingo Pharmaceuticals Limited | Comparative analysis of antibiotic susceptibility trends and bacterial resistance patterns among countries participating in the ATLAS program. - DATA CHALLENGE | Pfizer |
| 9049 | Shraddha Karve | Ashoka University | Data challenge - Novel approach to antibiogram analysis: looking at the composite resistance phenotype | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9050 | Yesmi Patricia Ahumada Santos | Universidad Autónoma de Sinaloa | Data Challenge-RESISTANCE TREND ANALYSIS OF MULTI-DRUG RESISTANCE REGISTERED FROM 2016 TO 2021 IN AMERICA COMPARED TO OTHER CONTINENTS | Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9052 | Rachael Kanguha | THARAKA NITHI COUNTY GOVERNMENT | DATA CHALLENGE: PATHOGEN PRESCRIPTION PREDICAMENT: ARE TREATMENT ALGORITHMS FOR THE WHO CRITICAL AND HIGH PRIORITY PATHOGENS APPROPRIATE? | Pfizer |
| 9054 | Mayibongwe Mzingwane | National University of Science and Technology | Data challenge: A predictive Tool on the Geospatial Clinical and Economic Impact of Antimicrobial Resistance (AMR) on paediatric and adult populations. | Pfizer |
| 9055 | Rogers Nsubuga | KABConsult, School of Public Health | Data Challenge - BROAD SPECTRUM ANTIBIOTIC RESISTANCE AMONG NEONATES IN AFRICA | Pfizer |
| 9056 | Jacob Wildfire | LSHTM/SGUL | Data Challenge - Exploration of how the distributions in MIC vary by key population groupings (such as age or infection type) | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9057 | Quentin Leclerc | Institut Pasteur | Data Challenge - Combining datasets to address AMR surveillance gaps | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9058 | Gboeze Christian Tochukwu | University of Nigeria | DATA CHALLENGE- PREDICTIVE ANALYSIS OF AMR TRENDS FOR HEALTHCARE DECISION MAKING AND FORECASTING (PATHFINDER) | Pfizer |
| 9059 | Yanhong Jessika Hu | Murdoch Children's Research Institute | Data Challenge - Global Geographic Patterns and Trends of WHO Priority Pathogens and AWaRe Antibiotic Resistances among Children: An Epidemiological Surveillance Study | Pfizer |
| 9060 | Innocent Oruru | Mbarara University of Science and Technology | ADMS(AI DRIVEN MALARIA DIAGNOSIS SYSTEM).data challenge | Venatorx |
| 9062 | Shadia Nakalema | INFECTIOUS DISEASES INSTITUTE, Makerere University | Data Challenge - Driving Evidence-Based Antibiotic Prescribing: Machine Learning-Enabled Point of Care Antibiograms for Improved Patient Care | Pfizer |
| 9063 | Joseph Harwell | Clinton Health Access Initiative | Trends in resistance to AWaRe drugs in Africa Data Challenge | Pfizer |
| 9064 | Louise Cerdeira | LSHTM | Data Challenge - An Evaluation of Klebsiella pneumoniae Antimicrobial Resistance Trends in LMICs | Pfizer, Venatorx |
| 9065 | Julius Kyomya | Mbarara University of Science and Technology | AMRIS data challenge | Pfizer, Venatorx |
| 9066 | Wilson Mudaki | University of Cape Town | Data Challenge - MICRES - Bridging the Gap in Antimicrobial Resistance Decision-Making | Pfizer |
| 9068 | Roshan Naik | Carmel College | DPT Data Challenge | Pfizer, Venatorx |
| 9069 | Randa Elsheikh | University of Edinburgh | Data Challenge - Monitoring the changes in the susceptibility pattern of Pseudomonas aeruginosa to seven classes of antibiotics in the Eastern Mediterranean region from 2004 to 2021. | Pfizer |
| 9070 | Duc Nguyen | Hanoi Medical Hospital | AMR through the eyes of machine learning - Data Challenge | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9072 | Irshaad Hoosain | University of Cape Town | AMR Data Challenge: CAP Pathogen AMR Patterns in LMICs | GSK, Pfizer |
| 9073 | Namubiru Saudah Kizito | Ministry of Health, Uganda | Projecting the Development of Antimicrobial Resistance to Beta-lactam Antibiotics in Africa: A Mathematical Modelling Approach | Pfizer |
| 9074 | Victoria Oladosu | Binghamton University | Data Challenge - Investigating the antibiotics resistance pattern of Pseudomonas aeruginosa and Staphylococcus aureus in patients with co-infections versus patients with mono-infections. | Paratek, Pfizer, Shionogi, Venatorx |
| 9075 | Nguyen Tien Huy | School of Tropical Medicine and Global Health, Nagasaki University | Assessing the Interplay between Antimicrobial Resistant Rates, Government Policy Interventions Worldwide, Vaccine Coverage, and Climate Change: An Empirical Study Utilizing Global Data_AMR Data Challenge | GSK, Paratek, Pfizer |
| 9084 | Ezekiel Jacobs | Global Health Research Unit, University of Ibadan | AMR Data Challenge - modelling and tracking colistin resistance in Africa | Pfizer, Venatorx |
| 9100 | Esther Syombua Ndaka | United States International University- Africa | Trends analysis of AMR in Kenya | Pfizer |
| 9109 | Tanvir Ahmed | Ministry of Health and Family Welfare, Bangladesh | RESISTANT CANDIDA AURIS AT INTENSIVE CARE UNITS IN ASIAN COUNTRIES: EVIDENCE FROM SENTRY ANTIMICROBIAL SURVEILLANCE PROGRAM | Pfizer |
| 9110 | Cory Kromer-Edwards | Machine Translation, LLC | Build MIC predictor using genomic data and antibiotic compounds using bacterial isolates | Pfizer |
| 9112 | Biel Garcias | Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona | Comparation Human AMR vs pets in Spain | Pfizer |
| 9113 | Tanvir Ahmed | Ministry of Health and Family Welfare, Bangladesh | Antibiotic Susceptibility in Children in Asia: Evidence from ATLAS Surveillance Study | Pfizer |
| 9118 | Varsha Shridhar | Molecular Solutions Care Health LLP | India Colistin & Carbapenem resistance study | Venatorx |
| 9391 | Tavpritesh Sethi | Indraprastha Institute of Information Technology Delhi | Machine Learning Modeling for Global Antimicrobial Resistance | GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, Venatorx |
| 9398 | Raunak Shrestha | Nepal Applied Mathematics & Informatics Institute (NAAMII) | Systems Genomics Modelling of Drug Resistance in Mycobacterium tuberculosis | Johnson & Johnson |
| 9408 | Sneha Kotian | Amsterdam UMC, AIGHD | Gender trends in bacterial AMR | Pfizer |
| 9414 | Jaxen Bream | Oakton High School | Assessment of an AI Model to Predict Antibiotic Effectiveness Against Bacterial Pathogens | Pfizer |
| 9435 | Virginia Pierce | University of Michigan Medical School | Evaluation of ampicillin-sulbactam breakpoints for Acinetobacter spp. | Shionogi |
| 9475 | Peyton Tebon | Gryphon Scientific, LLC | AMR in Chemical, Biological, Radiological, and Nuclear (CBRN) Events | Pfizer, Venatorx |
| 9733 | Antoine Villié | Aurobac Therapeutics | Epidemiology research on Gram-bacteria | Venatorx |
| 9762 | Joseph Acolatse | Cape Coast Teaching Hospital | Country comparison of AMR data to local data | Pfizer |
| 9956 | Bethani Pather | The Open University, UK | A comparative study of antimicrobial resistance prevalence between 2014 - 2020 in the UK and India | Venatorx, Pfizer, Merck |
| 10110 | Imran Sajid | Institute of Microbiology and Molecular Genetics (IMMG), University of the Punjab | Bioinformatics Analysis, AI and ML Analysis for Tracking Antimicrobial Resistance | GSK, J&J, Paratek, Pfizer, Shionogi, Venatorx |
| 10114, 10140 | Dailin Gan | University of Notre Dame | Building a synthetic control model for what the country incidence would have been without the vaccine intervention | GSK, J&J, Paratek, Pfizer, Shionogi, Merck, Venatorx |
| 10147 | Linta Khalid | National University of Science and technology, Pakistan | Bioinformatics analysis of bacterial genomic data to identify genetic markers associated with antimicrobial resistance | Merck, Pfizer |
| 10206 | Dallas Smith | Mycotic Diseases Branch, Centers for Disease Control and Prevention | Exploring antifungal minimum inhibitory concentrations to monitor for antifungal resistance globally through the 2024 Vivli AMR Surveillance Data Challenge | Pfizer |
| 10209 | Stephen Obol Opiyo | Patira Data Science, LLC | Empowering Global AMR Research Community: Interactive GIS Dashboards for AMR Data Analysis and Informed Decision-Making | GSK, J&J, Paratek, Pfizer, Shionogi, Merck, Venatorx |
| 10228 | Oruru Innocent | Mbarara university of science and technology | Data Challenge_TB-FUNGI DETECT-AI SYSTEM | Pfizer |
| 10269 | Judith Nanyunja | Makerere University | Data Challenge_Anticipating the Threat: A Machine Learning approach to predicting antimicrobial resistance (AMR) | Pfizer, Paratek, Venatorx, Merck |
| 10271 | Roshan Ratnakar Naik | Manhar Foundation | Data Challenge_AMR trends for India | Venatorx, Pfizer, Johnson & Johnson |
| 10274 | Miiro Chraish | Impala Healthtech Research | DIGAMS Data Challenge: Visualizing antimicrobial resistance trends on an open access dashboard, to guide prescribing practices. | Pfizer |
| 10276 | Kiirya Tevin Walter | KAWEMPE NATIONAL REFERRAL HOSPITAL | Data challenge_Neonatal sepsis at Kawempe Hospital Uganda | Pfizer, Paratek, Venatorx |
| 10278 | Adewale Ogunleye | Controlling Microbes to Fight Infection - Interfaculty Institute of Microbiology & Infection Medicine Tübingen (IMIT), University of Tuebingen, Germany | Data Challenge_Geography-Aware Optimization of Antimicrobial Combinations | Pfizer |
| 10311 | Naomi Waterlow | The London School of Hygiene & Tropical Medicine (LSHTM) | Data Challenge: What drives the global patterns in AMR prevalence by sex / gender? | Pfizer, GSK, Paratek, Johnson & Johnson, Venatorx, Shionogi |
| 10314 | Nelly Nyaga | IntelliSOFT Consulting Limited | Evaluating the Antibiotic Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae in Community-Acquired Respiratory Tract Infections (CA-RTIs) Across Countries Over a 3-Year Period. | GSK |
| 10315 | Sylvester Zibusiso Moyo | African Society for Laboratory Medicine (ASLM) | Data Challenge: Using Artificial Intelligence to predict antimicrobial resistance data disparities across Africa | Pfizer, Johnson & Johnson |
| 10316 | Dr Kamini Govender | University of the Free State (UFS) | Data Challenge:Harnessing Machine learning models for Enhanced Antimicrobial Resistance Surveilance and Intervention in African Countries. | Pfizer, Johnson & Johnson |
| 10318 | Kenneth Kariuki Irungu | MINISTRY OF HEALTH KENYA | DATA CHALLENGE: DEVELOPING A MODEL FOR PREDICTING BEDAQUILINE RESISTANCE IN MDR TB | Johnson & Johnson |
| 10321 | Tavpritesh Sethi | Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) | Data Challenge: Optimizing AMR Interventions with a Strategic Response Scorecard | Pfizer |
| 10323 | Agboeze, Christian Tochukwu | Global Health Research Unit - Genomic Surveillance of Antimicrobial Resistance, University of Ibadan | Data Challenge: Predicting AMR gene determinants and phenotypes | Pfizer |
| 10335 | Randa Elsheikh | Deanery of Biomedical Sciences, The University of Edinburgh | Data Challenge - Association between Global Migration Patterns and Antimicrobial Resistance: Trend Analysis from 2004 to 2022 | Pfizer, Venatorx |
| 10336 | Caesar Drileonzi | Muni Labs | Data challenge: Use of AI to model WHO priority pathogens and antibiotics from Africa using ATLAS dataset | Pfizer |
| 10339 | Swetha V. | Birla Institute of Technology And Science - Pilani | AMR surveillance: Data challenge | GSK, Johnson & Johnson, Paratek, Venatorx, Pfizer, Merck, Shionogi |
| 10340 | Emily Dickens | The University of Exeter | Data Challenge : Collateral sensitivity in antimicrobial susceptibility data | Pfizer |
| 10362 | Henry Wang | Byzantine Marine Holdings | Data Challenge - Individualized MIC estimations and optimal discrete time dosing policies | Pfizer |
| 10379 | Precious Simushi | Zambia National Public Health Reference Laboratory | Data challenge-Antimicrobial Resistance in Gram-Negative Pathogens: A Worldwide Perspective | Venatorx |
| 10382 | Cynthia Nduta Muregi | Mt Kenya University | Data Challenge- Community Acquired Pneumonia in Kenya | GSK |
| 10386 | Abiodun Kolapo | Africa Centres for Disease Control and Prevention | Data Challenge | Pfizer, Johnson & Johnson, GSK, Paratek, Venatorx, Shionogi |
| 10388 | Malambo Mutila | Empowerment and Resilience Network (EaRN) | Data Challenge - AMR Pattern-based Machine Learning Models | Pfizer, Johnson & Johnson |
| 10394 | Anthony Godswill Imolele | Helix Biogen Institute | Data Challenge_Genetic basis of AMR using advanced genomic analysis techniques | Pfizer, Paratek |
| 10396 | David R M Smith | University of Oxford | [Data Challenge] Advancing monitoring and prediction of antimicrobial resistance trajectories using flexible spatiotemporal modelling: A roadmap for early warning systems | Shionogi, GSK, Pfizer |
| 10397 | Harry Akligoh | Northeastern University | A novel AI laboratory platform to identify bacteria and AMR data challenge | Pfizer, Merck |
| 10400 | Muhammed Alimi | USMANU DAN FODIO UNIVERSITY YOUNG ANTIMICROBIAL RESISTANCE STEWARDS (UDUYARS) | 2024 Vivli AMR Surveillance Data Challenge | Pfizer, GSK, Johnson & Johnson, Paratek, Venatorx, Merck, Shionogi |
| 10402 | Linta Khalid | School of InSchool of Interdisciplinary Engineering & Science (School of Interdisciplinary Engineering & Science (SINES), National University of Sciences & Technology (NUST), Islamabad), National University of Sciences & Technology (NUST), Islamabad | Data Challenge_Machine Learning (ML) approach for Genotype Prediction Models for Antimicrobial Resistance | Pfizer |
| 10407 | B.M.C. Randika Wimalasiri Yapa | Microbio Ltd | Data Challenge_AMR pathogen prevalence | Pfizer, Paratek, Venatorx, Merck |
| 10410 | Rachael Kanguha Mmene | Chuka County Referral Hospital | Vivli 2024 data challenge: Clinical decision support: Merging AI, surveillance and literature for optimal antibiotic selection. | Pfizer, Paratek, Venatorx |
| 10412 | Vitali Luca A. | School of Pharmacy, University of Camerino, Camerino | Pharyngitis Data Challenge | Pfizer, Paratek |
| 10414 | Oscar Nyangiri | Kisii University | Data Challenge - AMR Triage | Pfizer, Venatorx |
| 10415 | Jake Hitch | University of Oxford | Data challenge - Unravelling the dependence between economic inequality and antimicrobial resistance: Distributional regression modelling to inform targeted public health investment | Pfizer, Venatorx |
| 10416 | Quentin Leclerc | Institut Pasteur | Data Challenge - AMR and sample types | Shionogi, Venatorx, Paratek, Pfizer |
| 10417 | Rahaf Abu Koura | London School of Hygine and Tropical Medicine (LSHTM) | C-AMR: Antimicrobial Resistance in Crisis-Affected Populations, Data Challenge | Pfizer, GSK, Johnson & Johnson, Paratek, Shionogi, Venatorx |
| 10418 | Nkosinathi Dlamini | Student University of Lusaka | AMR Data Challenge combat_Eswatini | Pfizer |
| 10419 | Nkosinathi Dlamini | Student University of Lusaka | MDR Data challenge_ESWATINI | Johnson & Johnson |
| 10420 | Vuciri Jude Rugga | Nzela AI Ltd | Development of “Vidata” a Standardized AMR Data Analysis and Visualization Tool - DATA CHALLENGE | Pfizer, GSK, Venatorx, Paratek |
| 10421 | Yanhong Jessika Hu | Murdoch Children's Research Institute | Data Challenge - Global Antimicrobial Resistance Burden in Children | Pfizer |
| 10422 | Rustam Shariq Mujtaba | Peach Health Asia | AMR VIVLI Multi-Region Data Challenge Project | Pfizer |
| 10423 | Ahmad I Al-Mustapha | University of Helsinki | Data Challenge | Pfizer |
| 10424 | Irishadullah-Akbar Sanusi | University Of Ibadan | Data Challenge - Mapping Global Antimicrobial Resistance species-wise and Creating an Online Vaccine Targets Repository Site. | Pfizer, GSK, Johnson & Johnson, Paratek, Venatorx, Shionogi |
| 10425 | Miriam Puschel | Kilimanjaro Christian Medical University College | Integrating AMR Trends and Genetic Data to Predict Bacterial Genealogy and Its Implications for One Health Data challenge. | Pfizer |
| 10426 | Shinah Arinda | African Centers of Excellence in Bioinformatics and Data Intensive Sciences | DATA CHALLENGE - A LONGITUDINAL STUDY FOR FORECASTING TRENDS IN AMR- A ONE-HEALTH APPROACH | Pfizer, GSK, Johnson & Johnson, Paratek, Venatorx, Shionogi |
| 10427 | Sasikala R | SASTRA DEEMED TO BE UNIVERSITY | Data Challenge: Exploring the evolution of multidrug resistance patterns in ESKAPE pathogens using association mining: Key to antibiotic stewardship? | Pfizer, Venatorx |
| 10429 | Neha Nityadarshini | All India Institute of Medical Sciences, New Delhi, India | Data challenge : Variables for accurate AMR prediction models | Pfizer, GSK, Johnson & Johnson, Paratek, Venatorx, Shionogi |
| 10430 | Jimmy Nkaiwuatei | Zihi Institute | AMR Data Challenge: Molecular epidemiology of beta-lactamase producing pathogens in Sub-Saharan Africa | Pfizer |
| 10431 | Essam Rosshdy | Infection prevention and control Consultant - AMR surveillance consultant | Data Challenge - Surveillance of colistin resistance among clinical isolates in low middle income countries and challenge of data utilization to inform decision makers under umbrella of one health approach | Pfizer |
| 10432 | Beatrice Wanjiku Chege | United States International University | Data Challenge - Group 1 Project 1 | GSK |
| 10433 | Max Van Wijk | IQVIA | Data Challenge: Understanding the validity of private data on AMR and the association between resistance rates of Gram negative bacterial infections and AMR policy indicators: a pooled analysis on four private datasets | Pfizer, Paratek, Venatorx, Shionogi |
| 10434 | Soe Yu Naing | Utrecht University | Data Challenge | Pfizer, Paratek, Venatorx, Shionogi |
| 10435 | Joseph Otoo | Centre for Research, Data Science and IT Solutions | Data Challenge - TRUSTED AI FOR MULTI-CHANNEL EARLY WARNING SYSTEM FOR EMERGING AMR THREATS | Pfizer, GSK, Johnson & Johnson, Paratek, Venatorx, Shionogi |
| 10436 | Arryn Craney | Petrified Bugs | Data Challenge: Candida Antifungal Breakpoint Explorer (CABE) | Pfizer |
| 10437 | Clintong Sekyere Frempong | Penuel Charis Consultancy Limited | Data Challenge - Mapping Resistance and Predicting Threats: A Comprehensive Study on AMR Trends and Early Detection in High-Risk Environments | GSK, Paratek, Johnson & Johnson, Pfizer |
| 10439 | Pei-Yu Huang | School of Public Health, University of Hong Kong | Data Challenge - Comparing Antimicrobial Resistance Profiles of Inpatients and Community Residents: Implications for Targeted Interventions | Pfizer |
| 10470 | Merlin Veronika Arokiamary | PSG Institute of Medical Sciences and Research | Blood stream infections of ESKAPEE pathogens | Pfizer |
| 10490 | Gregory Medlock | Vedanta Biosciences | Ecoli ceftriaxone | Pfizer |
| 10542 | Pei-Yu Huang | School of Public Health, University of Hong Kong | Assessment of potential clinical risk of commensal bacteria identified from the community in Hong Kong | Venatorx, Venus Remedies, Johnson & Johnson, Shionogi |
| 10547 | Swetha V. | Birla Institute of Technology And Science, Pilani | AMR India | Venus Remedies |
| 10705 | Sahar Heidari | Virginia Tech | Antifungal resistance prediction using deep learning | Pfizer |
| 10709 | Akshat Arora | Ashoka University | Antibiotic Resistance Surveillance in India | Pfizer |
| 10727 | Ts. Dr. Mohamad Izwan Bin Ismail | Universiti Teknologi MARA (UiTM) | A.baumannii resistance - Malaysia | Pfizer, Merck |
| 10780 | Avani Panickar | Medical and Biological Computing Laboratory, Vellore Institute of Technology | Respiratory Tract Bacterial Infection | Pfizer |
| 10874 | Elena Rosca | Ashesi University | Evaluating Machine Learning Algorithms for Predicting AMR | Pfizer |
| 10922 | Hellen Namulinda | Makerere University | Explainable Machine Learning Models for AMR Prediction in Africa | Pfizer |
| 10961 | Minnu Mariya | Ashoka University, Sonipat | Mycobacterium tuberculosis (MTB) drug resistance surveillance in the environment (wastewater) | Johnson & Johnson |
| 10962 | Abu Sayeed | National Centre for Epidemiology and Population Health, The Australian National University | AMR situations update on Salmonella spp in Australia | Pfizer |
| 11036 | Greg Medlock | Vedanta Biosciences | The prevalence of carbapenem-resistant Klebsiella spp. and extended-spectrum beta-lactamase producing E. coli | Pfizer, Venatorx, Merck |
| 11057 | Maroun Sfeir | Saint George Medical Center, lebanon | The susceptibility of respiratory pathogens globally | Pfizer |
| 11099 | Gisela Robles Aguilar | University of Oxford | Global Research on AntiMicrobial Resistance (GRAM) | Pfizer |
| 11164 | Erika Matuschek | EUCAST Development Laboratory | To create MIC distributions for anaerobic bacteria based on reference agar dilution | Pfizer |
| 11244 | Swetha V. | Birla Institute of Technology And Science, Pilani | AMR ML | Innoviva Specialty Therapeutics, Pfizer, Merck |
| 11279 | Nada Reza | University of Liverpool | Molecular Pharmacodynamics of Amoxicillin PhD | GSK |
| 11304 | Saurav Ajit Kulkarni | Arizona State University | AMR Surveillance Dashboard | Pfizer, Inc. |
| 11336 | Mohsen Naghavi | Director of Subnational Burden of Disease Estimation; University of Washington | Pfizer, Inc. | |
| 11343 | Richard Alm | CARB-X | Longitudinal surveillance by income status | GSK, Innoviva Specialty Therapeutics, Pfizer, Inc., Venatorx Pharmaceuticals, Venus Remedies |
| 11363, 11364, 11365, 11366, 11367, 11368, 11376, 11378, 11379, 11381, 11388, 11390 | Tarini Shankar Ghosh | Indraprastha Institute of Information Technology Delhi | Global profiling of AMR genes in gut microbiomes | Pfizer, Inc., Venatorx Pharmaceuticals, Venus Remedies, Shionogi, Johnson & Johnson, Paratek Pharmaceuticals, Inc,, Merck |
| 11431 | A Shivram | Birla Institute of Technology and Science Pilani, Hyderabad Campus | AMR PREDICTION | Pfizer, Inc. |
| 11459 | Christiane Dolecek | University of Oxford | The Global Research on Antimicrobial Resistance (GRAM) | Venatorx Pharmaceuticals, GSK, Innoviva Specialty Therapeutics, Merck, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Shionogi, Venus Remedies |
| 11568 | Lorena Cristina Correa Fehlberg | Pfizer Brazil | The goal is to evaluate the dataset to write an abstract for submission to the Brazilian Congress of Infectious Diseases. The analysis will focus solely on Brazil isolates. | Pfizer, Inc. |
| 11656 | Adeyemi Sarah Halleluyah | Morgan State University | Machine Learning-Based Classification of Antimicrobial Resistance in E. coli Genomes from Clinical Isolates | Merck, Pfizer, Inc. |
| 11698 | Mohammed Eslami | Netrias | Working to see if our AI Driven Harmonization technology can support harmonization of antibiotics, organism, and location annotations | Pfizer, Inc., GSK |
| 11751 | Kayoko Shioda | Boston University School of Public Health (BUSPH); Center on Emerging Infectious Diseases (CEID) | Boston University CEID One Health AMR study in Jharkhand, India | Pfizer, Inc. |
| 11406 | Abiodun Kolapo | Africa Centres for Disease Control and Prevention | Leveraging Data Challenge to combat Antimicrobial resistance: An Artificial Intelligence Approach | Venatorx Pharmaceuticals, Venus Remedies, Johnson & Johnson, Innoviva Specialty Therapeutics, GSK, Pfizer, Inc., Shionogi, Paratek Pharmaceuticals, Inc, |
| 11414 | Jake Hitch | University of Oxford | Data Challenge - Improving evidence-based antibiotic escalation in bloodstream infections in low-resource settings using Bayesian statistical and machine-learning approaches | ATLAS | Pfizer, Inc. |
| 11400 | Ahmed Nayeem | Ziauddin University | 2025 Data Challenge | Pfizer, Inc. |
| 11418 | Raphael Mutua | Kenya Medical Research Institute (KEMRI) | Predicting Antimicrobial Resistance from Clinic to Community: A One Health Machine Learning Data Challenge to Inform Antimicrobial Stewardship. | GSK, Pfizer, Inc. |
| 11404 | Rishabh Jain | City St Georges, University of London | Data Challenge - Leveraging machine learning to identify patterns in the structural and social determinants of AMR | Venatorx Pharmaceuticals |
| 11415 | George Priya Doss C | Vellore Institute of Technology | Data Challenge | Venus Remedies, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Venatorx Pharmaceuticals |
| 11347 | Roshan Naik | Diagopreutic Private Limited | Data Challenge: ASTPredIndia | Venus Remedies, Johnson & Johnson |
| 11440 | Monzur Patwary | Emory Univeristy | Data Challenge: Exploring Unequal Hotspots: State-Wise Disparities in India’s ’Red-Zone’ Hospitals for colistin-resistant klebsiella pneumoniae. | Venus Remedies |
| 11469 | Hellen Mwangi | Dedan Kimathi University of technology | Data Challenge: Applying Machine Learning Algorithms to Antimicrobial Resistance Data | Pfizer, Inc. |
| 11412 | Righteous Kwaku Agoha | DEPARTMENT OF BIOCHEMISTRY, CELL, AND MOLECULAR BIOLOGT, UNIVERSITY OF GHANA | DATA CHALLENGE _MY INNOVATIVE IDEA | Pfizer, Inc. |
| 11403 | Racheal Claire Kyomukama | African Centre of Excellence in Bioinformatics and Data Intensive Sciences | DATA CHALLENGE- MDRisk Stratify: AI-driven MDR Prediction for Optimized Antibiotic Use in LMICs | GSK, Pfizer, Inc., Innoviva Specialty Therapeutics, Venus Remedies, Venatorx Pharmaceuticals, Shionogi, Johnson & Johnson |
| 11405 | Claire Vania | Johns Hopkins University | Data Challenge: A Counterfactual Machine Learning Approach to Evaluating AMR Policy Impact | Venus Remedies, Venatorx Pharmaceuticals, Shionogi, Pfizer, Inc., Merck |
| 11391 | Ian Itolondo Mutoro | University of Nairobi | Data Challenge: Temporal Trends in Carbapenem Resistance of Klebsiella pneumoniae in Patient Isolates from Kenyan Hospitals Between 2013 and 2023 | Pfizer, Inc. |
| 11422 | George Wanjiru | UNIVERSITY OF CAMBRIDGE | Data Challenge - Machine Learning-Driven Mapping and Modeling of Antimicrobial Resistance Trends Using the ATLAS Dataset | Pfizer, Inc. |
| 11420 | Lilian Owino | Swiss TPH | 2025 Data Challenge - Optimizing Antibiotic Use: Forecasting Carbapenem Resistance Emergence via Shifts in MIC Distributions of Klebsiella pneumoniae and Escherichia coli | Pfizer, Inc. |
| 11411 | Quentin Leclerc | Conservatoire National des Arts et Métiers | Data Challenge - ECOFFs and clinical breakpoints | Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Shionogi, Venatorx Pharmaceuticals, GSK |
| 11423 | Jesic Beckham | City St George's University Of London | Data Challenge | Pfizer, Inc. |
| 11484 | Kolawole Temitope | Redeemer's Univeristy | Data Challenge: A Statistically-Driven Interactive Dashboard for Geo-Temporal Surveillance and Empirical Antibiotic Guidance | Pfizer, Inc. |
| 11498 | Umang Joshi | North Carolina State University | Data Challenge: Implementing Machine Learning for AMR trend recognition and projection | Venatorx Pharmaceuticals |
| 11496 | Marvellous Adeoye | University of Ibadan | Vivli Data Challenge: Genomic-Phenotypic Association for AMR Drug Target Discovery | Pfizer, Inc. |
| 11463 | Sathish Kumar Marimuthu | SASTRA Deemed to be University | Data Challenge: MDR-Predict: Fusing Genomic-Rich Artificial Intelligence Methods for Predicting Future Bacterial Multidrug Resistance Threats | Pfizer, Inc. |
| 11472, 1151, 11547 | Hanna Roenfanz | Hartford Hospital | 2025 Data Challenge | Innoviva Specialty Therapeutics, Pfizer, Inc., Venatorx Pharmaceuticals, Shionogi, Paratek Pharmaceuticals, Inc, |
| 11466 | Sean Nachtrab | Imperial College London | Vivli Data Challenge 2025 - Nachtrab | Venus Remedies, Paratek Pharmaceuticals, Inc,, GSK, Johnson & Johnson, Pfizer, Inc., Shionogi, Venatorx Pharmaceuticals, Innoviva Specialty Therapeutics |
| 11454 | Mike Nundwe | Zambia National Public Health Institute | Zambia AMRCC-Students Data Challenge | Pfizer, Inc. |
| 11482 | Sola Ogunmodede | Postgraduate student. Helix Biogen Institute/University of Lagos (Microbiology) | Mapping Resistance Patterns of Acinetobacter baumannii and Exploring Traditional Nigerian Herbs as Potential Therapeutic Alternatives: Insights from the Vivli AMR Data Challenge | Venatorx Pharmaceuticals, Innoviva Specialty Therapeutics |
| 11476 | Anthony Godswill | Helix Biogen Institute, Ogbomosho | Data Challenge: Implementing change-point detection algorithms across time-series resistance | Pfizer, Inc. |
| 11495 | Ayobami Akomolafe | University of Ibadan | DATA CHALLENGE- A retrieval-augmented generation–language model (RAG-LM) for immediate empirical antimicrobial prescription therapy | Shionogi, Venatorx Pharmaceuticals, Pfizer, Inc., Venus Remedies, Paratek Pharmaceuticals, Inc,, Johnson & Johnson, Innoviva Specialty Therapeutics, GSK |
| 11480 | Elizabeth Akande | Dept of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan | Data Challenge: TRACE-Ec: Transmission and Resistance Analytics for Carbapenem- and ESBL-producing E. coli | Pfizer, Inc. |
| 11468 | Daniel Sangeiro Cande | London School of Hygiene and Tropical Medicine | Data Challenge: Uncovering drivers and clusters of antibiotic resistance | Pfizer, Inc. |
| 11473 | Alejandro D. Nadra | Universidad de Buenos Aires - CONICET | Data Challenge: Network Analysis of Co-resistance Patterns in Candida Species | Pfizer, Inc. |
| 11479 | Chingasiyeni Chandapiwa Florence Chinodya | Sefako Makgato Health Sciences University | Data Challenge: Comparative Analysis of Surveillance Data and Infection Prevention and Control (IPC) Policies | Venatorx Pharmaceuticals |
| 11455 | Moses Njiru | Kenya Field Epidemiology Laboratory and Trainining Program (FELTP) | Empowering LMICs with AMR Intelligence: Open-Source data science training kit for scalable implementation_Data challenge | Venus Remedies, Shionogi, Pfizer, Inc., Paratek Pharmaceuticals, Inc,, Johnson & Johnson, Innoviva Specialty Therapeutics, GSK, Venatorx Pharmaceuticals |
| 11488 | Neha Nityadarshini | All India Institute of Medical Sciences, New Delhi | Data Challenge | Venatorx Pharmaceuticals, Shionogi, Pfizer, Inc., Venus Remedies, Innoviva Specialty Therapeutics |
| 11471 | Alexa Maria | Institut Pasteur/ Inserm / UVSQ | Data Challenge: Gene emergence | Pfizer, Inc. |
| 11493 | Adekemi Adepeju | University of Ibadan | Anticipating Resistance Risks to Cefiderocol in MDR Pathogens Data Challenge | Shionogi, Pfizer, Inc. |
| 11346 | Merlin Veronika Arokiamary | PSG Institute of Medical Sciences and Research | AMR Data Challenge 2025: Identifying patterns and drivers of AMR among pathogens in India | Venus Remedies |
| 11348 | Fabian Achangwi | Faculty of Medicine and Pharmaceutical Sciences | DISTRIBUTION OF MULTI DRUG AND EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING Escherichia coli isolated from laying hens and poultry farmers in AFRICA 2010 -2023 DATA CHALLENGE | Pfizer, Inc. |
| 11359 | Hassan Mbaraka Ruanda | Maweni Regional Referral Hospital, Western Tanzania | Data Challenge: Resistance Profiles of Uropathogenic Escherichia coli at Maweni Regional Referral Hospital, Tanzania" | Pfizer, Inc. |
| 11396 | Quetta Mulilya | Jomo Kenyatta University of Agriculture and technology(JKUAT) | Data Challenge: A. baumannii from a harmless passenger into a relentless pathogen | Pfizer, Inc. |
| 11398 | Nanyunja Judith | MAKERERE UNIVERSITY | Data Challenge: Identification of Conserved Plasmid Segments Carrying Mismatch Repair Genes, Mobile Genetic Elements, and Beta-Lactamase Resistance Variants (blaVIM, blaOXA-48, blaKPC) in Escherichia coli and Klebsiella pneumoniae1 | Venus Remedies, Venatorx Pharmaceuticals, Shionogi, Pfizer, Inc., Paratek Pharmaceuticals, Inc, |
| 11409 | Anthonio Oladimeji Gabriel | Center for Excellence in Modelling Population Health and Enviroment Risks(CEMPHER) | Data Challenge: Broad Spectrum Disperse Probabilistic Model to guide AMR stewardship using Mathematical and Spatial epidemics | Pfizer, Inc. |
| 11410 | Koen Pouwels | University of Oxford | Data Challenge: Estimating optimal empiric antibiotic therapy using Bayesian multivariate non-inferiority analyses | Pfizer, Inc. |
| 11433 | Frederick Akello | Malindi Sub-County Hospital, Kilifi county | Data challenge - Raptors | GSK, Innoviva Specialty Therapeutics, Johnson & Johnson, Venatorx Pharmaceuticals, Pfizer, Inc. |
| 11448 | Malambo Mutila | Empowerment and Resilience Network (EaRN) | Data Challenge: AMR Predictive Analytics Engine (AMR-PAE) | Shionogi, GSK, Innoviva Specialty Therapeutics, Johnson & Johnson, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Venus Remedies, Venatorx Pharmaceuticals |
| 11413 | Mouiche Moctar | Universite de Ngaoundere | HealthNexus Data challenge | Venatorx Pharmaceuticals |
| 11419 | Amel Kevin Alame Emane | Laboratoire National de Santé Publique | Data Challenge : Global Evaluation of Antimicrobial Resistance via Surveillance (Team LNSP) | Venatorx Pharmaceuticals |
| 11478 | Maryam Ebunoluwa Zakariya | University of Edinburgh | Data Challenge: Comparative Analysis of Antimicrobial Resistance Trends | Venatorx Pharmaceuticals |
| 11490 | Deeksha Pandey | University of Delhi | Data Challenge: AMR-Vision: MKULAB’s AI-Powered Laboratory Surveillance Tools | Innoviva Specialty Therapeutics |
| 11461 | Xiao Shuzhen | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, | 2025 challenge KP BSI | Pfizer, Inc. |
| 11416 | Yanhong Jessika Hu | Murdoch Children's Research Institute | Data Challenge: Global Surveillance of Resistance to Ampicillin–Gentamicin and Ceftriaxone in Children with Severe Infections: Evidence to Inform WHO AWaRe Guidelines | Innoviva Specialty Therapeutics |
| 11474 | Brian Matemba | KCMC University | Data challenge: Forecasting Pediatric Antimicrobial Resistance: A Spatiotemporal Analysis of Global Surveillance Data | Pfizer, Inc. |
| 11475 | Thi Mui Pham | Harvard T.H. Chan School of Public Health | Data Challenge - Quantifying the Impact of Extreme Weather on Antimicrobial Resistance using Synthetic Control Methods | Venus Remedies, Innoviva Specialty Therapeutics, Johnson & Johnson, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Shionogi, Venatorx Pharmaceuticals |
| 11481 | Tavpritesh Sethi | Professor, Department of Computational Biology, IIIT-Delhi | DATA CHALLENGE: An Open Platform to Uncover Associations between Health Systems Indicators and AMR Trajectories | Venus Remedies, Pfizer, Inc. |
| 11483 | Jude Vuciri Rugga | Nzela AI | DATA CHALLENGET - Development of a Web-Based Antimicrobial Resistance (AMR) Data Analysis and Reporting Tool | Venus Remedies, GSK, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Venatorx Pharmaceuticals |
| 11489 | Saloni Gole | Indian Institute of Technology Kharagpur | Data Challenge: Mapping India’s AMR Crisis: A Statistical and One Health Approach to Antibiotic Resistance Surveillance | GSK, Innoviva Specialty Therapeutics, Johnson & Johnson, Venus Remedies, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Shionogi, Venatorx Pharmaceuticals |
| 11499 | Lauren Hanna | Hightower Tech | Carbapenem Resistance: A Spatiotemporal Modeling Approach for the Vivli AMR Surveillance Data Challenge | Venus Remedies, Innoviva Specialty Therapeutics, Paratek Pharmaceuticals, Inc,, Pfizer, Inc., Shionogi |
| 11477 | Feifei Zhang | Peking University First Hospital | Data Challenge: "Beyond the Pandemic: Forecasting the Global Burden of Carbapenem-Resistant Respiratory Pathogens—A 20-Year Analysis of K. pneumoniae and P. aeruginosa LRTIs" | Pfizer, Inc. |
Center for Global Research Data